We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LUNG market cap is 227.18M. The company's latest EPS is USD -1.5788 and P/E is -3.74.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.54M | 17.19M | 17.67M | 19.28M | 18.85M |
| Operating Income | -16.4M | -16.44M | -15.18M | -13.92M | -14.54M |
| Net Income | -15.86M | -16.2M | -14.9M | -13.89M | -13.75M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 32.6M | 32.73M | 48.42M | 53.66M | 68.68M |
| Operating Income | -17.84M | -32.33M | -47.3M | -58.64M | -61.94M |
| Net Income | -20.7M | -32.23M | -48.66M | -58.92M | -60.84M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 201.27M | 193.11M | 185.02M | 177.78M | 164.58M |
| Total Liabilities | 57.34M | 59.16M | 59.27M | 59.47M | 54.09M |
| Total Equity | 143.93M | 133.95M | 125.74M | 118.32M | 110.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 53.53M | 263.71M | 235.17M | 193.68M | 177.78M |
| Total Liabilities | 35.57M | 37.57M | 41.93M | 39.67M | 59.47M |
| Total Equity | -187.38M | 226.13M | 193.24M | 154.01M | 118.32M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.64M | -20.54M | -29.16M | -37.61M | -11.8M |
| Investing | 574k | -239k | 748k | -2.01M | -2.51M |
| Financing | 20.72M | 20.81M | 21.38M | 21.4M | 864k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.77M | -30.63M | -41.39M | -45.08M | -37.61M |
| Investing | -14.23M | 12.69M | -46.26M | -4.23M | -2.01M |
| Financing | 45.62M | 234.83M | 4.46M | 2.42M | 21.4M |
| Market Cap | 227.18M |
| Price to Earnings Ratio | -3.74 |
| Price to Sales Ratio | 3.31 |
| Price to Cash Ratio | 2.72 |
| Price to Book Ratio | 1.92 |
| Dividend Yield | - |
| Shares Outstanding | 38.54M |
| Average Volume (1 week) | 578.94k |
| Average Volume (1 Month) | 424.17k |
| 52 Week Change | -53.21% |
| 52 Week High | 14.92 |
| 52 Week Low | 5.67 |
| Spread (Intraday) | 2.23 (27.94%) |
| Company Name | Pulmonx Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.pulmonx.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
